In the search for stroke genes: A long and winding road

American Journal of Hypertension

Volumn 17, Issue 2, 2004, Pages 197-202

  Rubattu, Speranza ^a,b   Gigante, Bruna ^a   Stanzione, Rosita ^a   De Paolis, Paola ^b   Tarasi, David ^b   Volpe, Massimo ^a,b  

^a IRCCS NEUROMED   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Atrial natriuretic peptide; Cerebrovascular accidents; Genetics; Intermediate phenotype

Indexed keywords

ATRIAL NATRIURETIC FACTOR;

CEREBROVASCULAR ACCIDENT; CORONARY RISK; DISEASE PREDISPOSITION; EXPERIMENTAL MODEL; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC EPISTASIS; GENETIC HETEROGENEITY; GENETIC LINKAGE; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT STRAIN; REVIEW; RISK FACTOR; STROKE;

EID: 1642493773     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2003.10.011     Document Type: Review

References (52)

1. The World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva: World Health Organization, 2002.
2. Kjeldsen S.E., Julius S., Hedner T., Hansson L. Stroke is more common than myocardial infarction in hypertension analysis based on 11 major randomized intervention trials . Blood Press. 10:2001;190-192.
3. Rubattu S., Giliberti R., Volpe M. Etiology and pathophysiology of stroke as a complex trait. Am J Hypertens. 13:2000;1139-1148.
4. Kiely D.K., Wolf P.A., Cupples L.A., Beiser A.S., Myers R.H. Familial aggregation of stroke. The Framingham study. Stroke. 24:1993;1366-1371.
5. Jousilahti P., Rastenyte D., Tuomilehto J., Sarti C., Vartiainen E. Parental history of cardiovascular disease and risk of stroke. A prospective follow-up of 14371 middle-aged men and women in Finland. Stroke. 28:1997;1361-1366.
6. Welin L., Svardsudd K., Wilhelmsen L., Larsson B., Tibblin G. Analysis of risk factors for stroke in a cohort of men born in 1913. N Engl J Med. 317:1987;521-526.
7. Brass L.M., Isaacson J.L., Merikangas K.R., Robinette C.D. A study of twins and stroke. Stroke. 23:1992;221-223.
8. Dichgans M. Monogenic causes of ischaemic stroke. Markus H. Stroke Genetics. 2003;127-163 Oxford University Press, Oxford.
9. Okamoto K., Yamori Y., Nahaoka A. Establishment of the stroke-prone spontaneously hypertensive rat (SHR). Circ Res. 33/34:(Suppl I):1974;I143-I153.
10. Rubattu S., Volpe M., Kreutz R., Ganten U., Ganten D., Lindpaintner K. Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human disease. Nat Genet. 13:1996;429-434.
11. Jeffs B., Clark J.S., Anderson N.H., Gratton J., Brosnan M.J., Gauguier D., Reid J.L., Macrae I.M., Dominiczak A.F. Sensitivity to cerebral ischaemic insult in a rat model of stroke is determined by a single genetic locus. Nat Genet. 16:1997;364-367.
12. Knoblauch M., Struk B., Rubattu S., Lindpaintner K. Genetic and congenic mapping of loci for blood pressure and blood pressure-related phenotypes in the rat. Dominiczak A.F., Connell J.M.C., Soubrier F. Molecular Genetics of Hypertension. 1999;53-72 Bios Scientific, Oxford, UK.
13. Rubattu S., Ganten U., Volpe M., Lindpaintner K. Increased incidence of stroke in congenic rats carrying the SHRSP-derived stroke-related locus, STR-1. (Abstract) Circulation. 100:(Suppl 1):1999;1-275.
14. Rubattu S., Lee M.A., De Paolis P., Giliberti R., Lombardi A., Gigante B., Volpe M., Lindpaintner K. Altered structure, regulation and function of the gene encoding atrial natriuretic peptide in the stroke-prone spontaneously hypertensive rat. Circ Res. 85:1999;900-905.
15. Rubattu S., Giliberti R., De Paolis P., Stanzione R., Spinsanti P., Venturelli V., Volpe M. Effect of a regulatory mutation on atrial natriuretic peptide gene transcription. Peptides. 23:2002;555-560.
16. th Scientific Meeting of the International Society of Hypertension, Milan 2003. J Hypertens 2003;21(Suppl 4):S239.
17. Vesely D.L. Atrial natriuretic peptide prohormone gene expression hormones and diseases that upregulate its expression . IUBMB Life. 53:2002;153-159.
18. Ikeda M., Kohno M., Takeda T. Inhibition by cardiac natriuretic peptides of rat vascular endothelial cell migration. Hypertension. 26:1995;401-405.
19. Itoh H., Pratt R.E., Dzau V.J. Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J Clin Invest. 86:1990;1690-1697.
20. Kook H., Itoh H., Choi B.S., Sawada N., Doi K., Hwang T.J., Kim K.K., Arai H., Baik Y.H., Nakao K. Physiological concentration of atrial natriuretic peptide induces endothelial regeneration in vitro. Am J Physiol. 284:2003;H1388-H1397.
21. Rubattu S., Russo R., Vecchione C., Ganten D., Savoia C., Morella A., Lindpaintner K., Volpe M. Identification of adrenomedullin as a candidate gene in the stroke-prone phenotype of spontaneously hypertensive rats (SHRSP). Am J Hypertens. 11:(Suppl):1998;5A-6A.
22. Sakata J., Shimokubo T., Kitamura K., Nakamura S., Kangawa K., Mtsuo H., Eto T. Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Bioch Biophys Res Commun. 195:1993;921-927.
23. Sato A., Canny B.J., Autelitano D.J. Adrenomedullin stimulates aAMP accumulation and inhibits atrial natriuretic peptide gene expression in cardiomyocytes. Bioch Biophys Res Commun. 230:1997;311-314.
24. Watanabe T, Ishinaga Y, Hanaka S, Liang Y-Q, Inomata H, Isobe M, Nabika T, Kato N: Evaluation of the adrenomedullin gene as a candidate for chromosome 1 QTL in stroke-prone SHR (Abstract). J Hypertens 2002;20(Suppl 4):S260.
25. Hassan A., Markus H. Genetics and ischaemic stroke. Brain. 123:2000;1784-1812.
26. Markus H., Barley J., Lunt R., Blunt J.M., Jeffery S., Carter N.D., Brown M.M. Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not for carotid atheroma. Stroke. 26:1995;1329-1333.
27. Zee R.Y., Ridker P.M., Stampfer M.J., Hennekens C.H., Lindpaintner K. Prospective evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of stroke. Circulation. 99:1999;340-343.
28. Sharma P. Meta-analysis of the ACE gene in ischaemic stroke. J Neurol Neurosurg Psychiatry. 64:1998;227-230.
29. Rubattu S., Ridker P.M., Stampfer M., Volpe M., Hennekens C.H., Lindpaintner K. The gene encoding atrial natriuretic peptide and the risk of human stroke. Circulation. 100:1999;1722-1726.
30. Evangelista A, Zanda B, Tarasi D, Gigante B, Pirisi A, Brunetti E, Volpe M: The atrial natriuretic peptide gene polymorphisms and the risk of ischemia stroke in humans. Stroke 2004 (in press).
31. Vesely D.L., Douglass M.A., Dietz J.R., Gower W.R., McCormick M.T., Rodriguez-Paz G., Schocken D.D. Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce a diuresis, diuresis and/or kaliuresis in humans. Circulation. 90:1994;1129-1140.
32. Dietz J.R., Scott D.Y., Landon C.S., Nazian S.J. Evidence supporting a physiological role for proANP-(1-30) in the regulation of renal excretion. Am J Physiol. 280:2001;R1510-R1517.
33. Vesely D.L. Atrial natriuretic peptides in pathophysiological diseases. Cardiovasc Res. 51:2001;647-658.
34. Nannipieri M., Manganiello M., Pezzatini A., De Bellis A., Seghieri G., Ferrannini E. Polymorphisms in the hANP (human atrial natriuretic peptide) gene, albuminuria, and hypertension. Hypertension. 37:2001;1416-1422.
35. Gruchala M., Ciecwierz D., Wasag B., Targonski R., Dubaniewicz W., Nowak A., Sobiczewski W., Ochman K., Romanowski P., Limon J., Rynkiewicz A. Association of the Sca I atrial natriuretic peptide gene polymorphism with nonfatal myocardial infarction and extent of coronary artery disease. Am Heart J. 145:2003;125-131.
36. Hassan A., Ali N., Dong Y., Carter N.D., Markus H.S. Atrial natriuretic peptide gene G664A polymorphism and the risk of ischemic cerebrovascular disease. Neurology. 577:2001;1726-1728.
37. Kato N., Ikeda K., Nabika T., Morita H., Sugiyama T., Gotoda T., Kurihara H., Kobayashi S., Yazaki Y., Yamori Y. Evaluation of the atrial natriuretic peptide gene in stroke. Atherosclerosis. 163:2002;279-286.
38. Gretasdottir S., Sveinbjornsdottir S., Jonsson H.H., Jakobsson F., Einarsdottir E., Agnarsson U., et al. Localization of a susceptibility gene for common forms of stroke to 5q12. Am J Hum Genet. 70:2002;593-603.
39. Dichgans M. CADASIL a monogenic condition causing stroke and subcortical vascular dementia . Cerebrovasc Dis. 13:(Suppl 2):2002;37-41.
40. Artavanis-Tsakonas S., Rand M.D., Lake R.J. Notch signaling cell fate control and signal integration in development . Science. 284:1999;770-776.
41. Joutel A., Corpechot C., Ducros A., Vahedi K., Chabriat H., Mouton P., Alamowitch S., Domenga V., Cecillion M., Marechal E., Maciazek J., Vagssiere C., Cruaud C., Cabanis E.A., Ruchoux M.M., Weissenbach J., Bach J.F., Bousser M.G., Tournier-Lasserve E. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 383:1996;707-710.
42. Joutel A., Dodick D.D., Parisi J.E., Cecillon M., Tournier-Lasserve E., Bousser M.G. De novo mutation in the Notch3 gene causing CADASIL. Ann Neurol. 47:2000;388-391.
43. Ito D., Tanahashi N., Murata M., Sato H., Saito I., Watanabe K., Fukuuchi Y. Notch3 gene polymorphism and ischemic cerebrovascular disease. J Neurol Neurosurg Psychiatry. 72:2002;382-384.
44. Duggirala R., Gonzalez V.C., O'Leary D.H., Stern M.P., Blangero J. Genetic basis of variation of carotid artery wall thickness. Stroke. 27:1996;833-837.
45. Stensland-Bugge E., Bonaa K.H., Joakimsen O. Age and sex differences in the relationship between inherited and lifestyle risk factors and subclinical carotid atherosclerosis the Tromso Study . Atherosclerosis. 154:2001;437-448.
46. Jartti L., Ronnemaa T., Kaprio J., Jarvisaio M.J., Toikka J.O., Marniemi J., Hammar N., Alfredsson L., Saraste M., Hartiala J., Koskenvuo M., Raitakari O.T. Population-based twin study of the effects of migration from Finland to Sweden on endothelial function and intima-media thickness. Arter Thromb Vasc Biol. 22:2002;832-837.
47. Carmelli D., DeCarli C., Swan G.E., Jack L.M., Reed T., Wolf P.A., Miller B.L. Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke. 29:1998;1177-1181.
48. Volpe M., Iaccarino G., Vecchione C., Rizzoni D., Russo R., Rubattu S., Trimarco B., Lindpaintner K. Association and co-segregation of stroke with impaired-endothelium dependent vasorelaxation in stroke-prone, spontaneously hypertensive rats. J Clin Invest. 98:1996;256-261.
49. Rubattu S., Giliberti R., Russo R., Gigante B., Ganten U., Volpe M. Analysis of the genetic basis of the endothelium-dependent impaired vasorelaxation in the stroke-prone spontaneously hypertensive rat a candidate gene approach . J Hypertens. 18:2000;161-165.
50. Gigante B, Rubattu S, Stanzione R, Lombardi A, Schiavoni M, Tarasi D, Volpe M: Absence of genetic factors underlying the impaired endothelium- dependent vasorelaxation in the stroke-prone spontaneously hypertensive rat. High Blood Pressure and Cardiovasc Prev (in press).
51. Gigante B., Rubattu S., Zee R., Volpe M., Lindpaintner K. Non-random chromosomal distribution of SSLPs systematic assessment using a novel genetic linkage map between two closely related rat strains . Cytogenet Cell Genetics. 95:2001;64-72.
52. Gigante B., Rubattu S., Stanzione R., Lombardi A., Baldi A., Baldi F., Volpe M. Contribution of genetic factors to renal lesions in the stroke-prone spontaneously hypertensive rat. Hypertension. 42:2003;702-706.